Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.
about
Healing scars: targeting pericytes to treat fibrosisGenetic tools for identifying and manipulating fibroblasts in the mouseKidney pericytes: roles in regeneration and fibrosis.Recent advances in the understanding of acute kidney injury.Defective pericyte recruitment of villous stromal vessels as the possible etiologic cause of hydropic change in complete hydatidiform moleInflammatory PAF Receptor Signaling Initiates Hedgehog Signaling and Kidney Fibrogenesis During Ethanol Consumption.Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosisGli1+ Pericyte Loss Induces Capillary Rarefaction and Proximal Tubular Injury.Progression of chronic kidney disease: too much cellular talk causes damage.Microsphere-Based Rapamycin Delivery, Systemic Versus Local Administration in a Rat Model of Renal Ischemia/Reperfusion Injury.Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice.Epoxyeicosatrienoic acid activation moderates endothelial mesenchymal transition to reduce obstructive nephropathy.Stat3 Controls Tubulointerstitial Communication during CKD.Abnormal expression of fibrosis markers, estrogen receptor α and stromal derived factor‑1/chemokine (C‑X‑C motif) receptor‑4 axis in intrauterine adhesions.Effects of Biejia Ruangan Tablet-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts.Parabiosis and single-cell RNA sequencing reveal a limited contribution of monocytes to myofibroblasts in kidney fibrosis.
P2860
Q26825838-DD34CDCC-26D4-432E-9D39-648CF1F63862Q28392538-E35A6DF9-B08C-4AA8-A3C1-20D6369E67CEQ34176024-9D7C86B9-764A-4D12-980B-155D833B4C5AQ34201916-DBFB9F66-D26C-4650-B76F-5C41F0050187Q35303697-1EA6445D-1A05-4599-B72F-692ED5A664C3Q35882616-348A9F4B-83E2-4001-81C1-64E662C18A63Q36040432-38FF0FEC-6F0A-4628-83FF-5AC851396DD5Q37688355-A96EBC3B-3F3F-40EA-B69C-59E6B5EBA985Q38821608-CA80CEA2-A804-4FE4-9F63-E84A5D55D3AEQ38988806-FE5B0E27-A55B-43C7-BA82-8583600806E3Q43244555-78775055-681E-4D25-AB86-3FE987339767Q47139383-9BAA4875-E203-4162-8553-F2EF7644579AQ47148741-2F1DF2D4-6A32-42EE-8022-E08C60E16829Q50349533-76F9B7B7-E3D9-4D49-B25E-C9759BF18E33Q52641323-0E37B2FB-E8AF-4FAE-84CB-835E87F7645CQ53660961-3A9884F9-7C2D-4C87-9869-2E8447192CC9Q55375727-35B2DE62-B27B-4750-B348-99C01B8D4AC1
P2860
Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.
@en
Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.
@nl
type
label
Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.
@en
Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.
@nl
prefLabel
Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.
@en
Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation.
@nl
P2093
P2860
P1476
Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation
@en
P2093
Benjamin D Humphreys
Derek P Dirocco
Omar H Maarouf
P2860
P2888
P356
10.1007/S40139-013-0026-7
P577
2013-12-01T00:00:00Z